2m 2m 2m 2m 2m 2m 2m
Pharma-Bio Serv (PBSV)
OTC
$0.57-$0.01 (-2.59%)
Price as of May 28, 2026- $12.9MMarket Cap
- 9.71%1-Year Change
- Health Information ServicesIndustry
Pharma-Bio Serv (PBSV)
$0.57-$0.01 (-2.59%)
Annual
Quarterly
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.0M -5.34% | 9.5M -43.99% | 17.0M -12.48% | 19.4M -3.56% | |
Cost of Revenue | 6.1M -12.90% | 7.0M -41.28% | 11.9M -17.96% | 14.5M -1.61% | |
Gross Profit | 2.9M +15.66% | 2.5M -50.34% | 5.1M +3.79% | 4.9M -8.93% | |
Sales and Marketing Expense | 3.5M -6.73% | 3.8M -3.68% | 3.9M +6.54% | 3.7M -59.77% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 59,866 +156.81% | 23,311 -51.52% | 48,086 -5.91% | 51,107 -29.73% | |
Total Operating Expenses | 3.5M -6.73% | 3.8M -3.68% | 3.9M +6.54% | 3.7M -59.77% | |
Operating Profit | -637,662 -50.48% | -1.3M -215.23% | 1.1M -4.90% | 1.2M +130.49% | |
Interest Income | 37,526 -84.73% | 245,815 -23.20% | 320,077 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 37,526 -84.73% | 245,815 -23.20% | 320,077 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 543,402 +2.12% | 532,139 -6.65% | 570,076 +4,148.59% | 13,418 -99.32% | |
Income before Taxes | -94,260 -87.52% | -755,448 -144.77% | 1.7M +42.00% | 1.2M +163.35% | |
Income Taxes | 6,203 -72.02% | 22,171 -94.12% | 377,307 +107.68% | 181,679 -14.80% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -100,463 -87.08% | -777,619 -159.35% | 1.3M +30.15% | 1.0M +148.18% | |
Net Income from Continuing Operations Applicable to Common | -94,260 -87.52% | -755,448 -144.77% | 1.7M +42.00% | 1.2M +163.35% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.004 -88.24% | -0.03 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 22.9M -0.08% | 23.0M -0.02% | 23.0M -0.14% | 23.0M -0.10% | |
Diluted Weighted Average Shares | 23.0M -0.08% | 23.0M -0.10% | 23.0M -0.15% | 23.0M -0.56% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.4M -50.07% | 6.8M -35.22% | 10.4M -27.77% | 14.5M -17.21% | |
Short-Term Investments | 7.5M +25.05% | 6.0M +31.93% | 4.5M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 10.9M -14.84% | 12.7M -14.90% | 15.0M +3.56% | 14.5M -17.21% | |
Total Current Assets | 13.4M -14.73% | 15.7M -19.08% | 19.4M -2.72% | 19.9M -12.61% | |
Accumulated Depreciation | 199,929 -69.63% | 658,249 +3.66% | 635,009 +8.16% | 587,089 +9.05% | |
Property and Plant and Equipment and Net | 116,059 -31.44% | 169,281 +415.33% | 32,849 -55.42% | 73,684 -30.17% | |
Total Long-Term Assets | 120,754 -46.47% | 225,599 +102.03% | 111,665 -14.68% | 130,874 -62.96% | |
Total Assets | 13.7M -16.20% | 16.3M -18.14% | 19.9M -3.63% | 20.7M -13.67% | |
Income Taxes Payable | 718,796 +20.95% | 594,316 +11.34% | 533,782 +58.27% | 337,264 -85.34% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.7M -7.86% | 1.9M -12.37% | 2.2M +2.18% | 2.1M -20.50% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 28,834 -85.14% | 194,035 -44.00% | 346,509 -28.90% | |
Total Liabilities | 1.7M -32.52% | 2.6M -31.74% | 3.8M -7.77% | 4.1M -18.25% | |
Retained Earnings | 10.5M -14.74% | 12.4M -16.83% | 14.9M -2.71% | 15.3M -13.78% | |
Total Stockholders Equity | 11.9M -13.13% | 13.7M -14.95% | 16.1M -2.60% | 16.6M -12.46% | |
Total Shares Outstanding | 22.9M -0.23% | 23.0M -0.02% | 23.0M +0.09% | 22.9M -0.26% | |
Cash Flow | |||||
Cash from Operating Activities | -214,886 -62.08% | -566,701 -129.97% | 1.9M +219.17% | 592,457 -26.39% | |
Capital Expenditures | 6,644 -95.84% | 159,743 +2,103.05% | 7,251 -62.37% | 19,269 +77.68% | |
Cash from Investing Activities | -1.5M +7.75% | -1.4M -67.74% | -4.2M +21,791.84% | -19,269 -101.49% | |
Dividends Paid | 1.7M -0.13% | 1.7M -0.09% | 1.7M -49.98% | 3.4M +99.53% | |
Cash from Financing Activities | -1.8M +1.03% | -1.7M -1.40% | -1.8M -50.17% | -3.5M +101.25% | |
Financials Ratio | |||||
Gross Margin | 32.33% +22.19% | 26.46% -11.34% | 29.84% +18.59% | 25.16% -5.56% | |
Operating Margin | -7.08% -47.68% | -13.54% -305.72% | 6.58% +8.67% | 6.06% +131.61% | |
Return on Assets | -0.67% -84.38% | -4.30% -166.50% | 6.46% +43.05% | 4.52% +158.20% | |
Return on Equity | -0.78% -84.96% | -5.21% -165.01% | 8.02% +41.25% | 5.68% +156.55% | |
Revenue Growth | -5.34% -87.85% | -43.99% +252.33% | -12.48% +250.53% | -3.56% -47.00% | |
Current Ratio | 7.70 -7.45% | 8.32 -7.66% | 9.01 -4.80% | 9.46 +9.92% | |
Cash Ratio | 1.94 -45.81% | 3.59 -26.07% | 4.85 -29.31% | 6.86 +4.14% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow